Trial Profile
A clinical study to evaluate prehospital use of Hemopure® (Hemoglobin glutamer-250) in trauma patients
Status:
Planning
Phase of Trial:
Phase IV
Latest Information Update: 22 Nov 2018
Price :
$35
*
At a glance
- Drugs Hemoglobin glutamer (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- 22 Nov 2018 New trial record
- 08 Nov 2018 According to a HbO2 Therapeutics media release, patient enrollment is expected to commence in mid 2019.